Population pharmacokinetics of CNTO 95, a human anti-{alpha}v integrin antibody, in patients with solid tumors

e14593 Background: CNTO 95 is a human anti-αv integrin antibody. The dose-dependent antitumor effect of CNTO 95 has been demonstrated in multiple preclinical studies. The objective of these analyse...